Should ß blockers no longer be considered first-line therapy for the treatment of essential hypertension without comorbidities?
Should ß blockers no longer be considered first-line therapy for the treatment of essential hypertension without comorbidities? Curr Cardiol Rep. 2011 Dec; 13(6):507-16.